O rganizations around the world produce clinical practice guidelines at an astonishing pace, with great effort and at substantial cost. 1 Unfortunately, despite broad dissemination efforts, large gaps remain between guideline recommendations and real-world practice across health systems, practitioner and patient types, and diseases. 2 Conventional approaches to guideline implementation use the guideline as a starting point and manipulate factors external to the guideline (e.g., provider knowledge and practice workflow) to optimize its uptake. 1 However, it is becoming increasingly clear that certain features of the guideline itself may also influence its uptake. We explore how the language and format used in a guideline may affect how likely it is to be followed in real-world practice. We offer practical tips to optimize these features in an effort to increase a guideline's uptake.
Why don't clinicians use guidelines?
Clinicians complain that guidelines are too lengthy, ambiguous and complex [3] [4] [5] and that they are presented in too rigid a fashion for practical application in individual cases. [6] [7] [8] [9] In a review of 41 qualitative studies, incomprehensible structure, poor usability and poor local applicability of guidelines were identified as the key barriers to their implementation. 10 In particular, primary care physicians perceive barriers and facilitators to guideline uptake almost exclusively according to their format, language and usability. 11 Accordingly, the style in which a guideline is written (e.g., providing suggested actions rather than prohibitive rules) influences how it is received and whether it will be followed. 12 In an observational study involving general practitioners in the Netherlands, vague and imprecisely defined recommendations were followed in 36% of clinical decisions, whereas clear recommendations were followed in 67% of decisions. 13 The influence of these "intrinsic" guideline characteristics 14 on clinicians' intention to practise and their actual practise of recommended behaviours has been recognized for more than a decade. 13, [15] [16] [17] Recently, an extensive review of these characteristics 18 has enabled the development and validation of a set of key principles to optimize the implementability of guidelinesthe Guideline Implementability for Decision Excellence Model (GUIDE-M) (Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/ cmaj.151102/-/DC1). These principles include (a) credible and representative developers of guideline content, (b) high-quality synthesis and contextualization of evidence for creating guideline content and (c) optimal use of language and format to convey recommendations.
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Why are the language and format of guidelines so important?
A growing body of literature suggests that the language of recommendations has to be simple, clear and persuasive to reduce cognitive load, increase understanding and retention, and render convincing and salient arguments. 18 The level of complexity is inversely proportional to overall guideline adoption 20, 21 and adherence to recommendations. 22, 23 At the same time, a number of formatting aspects of guidelines can help to promote their use in practice. 12, 24 These include presentation aspects such as a user-friendly layout (e.g., considering document length and the placement of visual elements), structure (e.g., bundling information and matching the order and flow of recommendations to that of real-world practice) and how information is best visualized (e.g., conveying complex recommendations through tables, graphs and flowcharts). Some of these common design principles for scientific communication have an empirical foundation, whereas many others are derived from best practices and user preferences. However, because most formatting principles are based on cognitive processes, they are likely to be generalizable across disciplines and contexts. 18 Studies have shown that efforts to improve language and format according to best evidence Optimizing the language and format of guidelines to improve guideline uptake can improve the uptake of recommendations. In a randomized controlled trial (RCT) of guideline writing styles, a more specific and actionable recommendation increased appropriate ordering of tests and decreased inappropriate ordering. 25 Furthermore, compared with no guideline at all, the nonspecific guideline led to a decrease in appropriate ordering, 25 which suggests that a poorly written guideline may be harmful. In another RCT, evidence-based improvements to language style and specificity of recommendations in a guideline led to users having stronger intentions to implement the recommendations, greater perceived control over their ability to implement guideline-recommended behaviours and more positive attitudes toward the guideline, compared with the original version.
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Examples from recent guidelines
To illustrate some of these concepts, we have chosen examples from the latest guidelines for three of the most common chronic conditions in Canada: diabetes, asthma and ischemic heart disease. 26 In each example, we display a recommendation from a published guideline and highlight problem areas related to the corresponding language or format "construct" (where relevant, we also highlight issues related to the creation of content). We then present a suggested revision of the recommendation that attempts to address these problems. (More detailed descriptions of the constructs are presented in Appendix 2, available at www.cmaj.ca/lookup/ suppl/doi: 10.1503/cmaj.151102/-/DC1.) A member of each original guideline committee was asked to comment on these issues and to provide content expertise in crafting the revised recommendations (A.Y.Y.C. for diabetes, K.A.C. for ischemic heart disease, and L.P.B. for asthma). Although format is no less important than language, each example raised multiple language-related issues, but only a few format-related ones; therefore, most of the highlighted issues relate to language. Figure 1 features several examples of ambiguous language in a recommendation from the Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. 27 Ambiguity arises when guidelines do not clearly and consistently specify recommended actions and parameters on which decisions should be based. 23, 28 This can lead to vague recommendations that are unlikely to guide practice in a meaningful way. 29 The first bullet point in the recommendation in Figure 1 is conditional on a situation in which "glycemic control is not being achieved." Failure to provide a definition of suboptimal glycemic control introduces semantic ambiguity, whereby different users of the guideline may reasonably interpret this condition in different ways. The same bullet point recommends "training of healthcare providers and patients." However, both the nature of this training and how this task should be operationalized are unclear 23 (e.g., should health care providers receive the training first and then train their patients, or should both health care providers and patients undergo the same training simultaneously?), which introduces task ambiguity.
Example 1
The recommendation in Figure 1 also fails to identify which of the several possible health care providers typically involved in diabetes care should undergo the training or assume responsibility for subsequent patient training (e.g., primary care physicians might think that the recommendation is aimed exclusively at specialists, and vice versa). This introduces responsibility ambiguity. 23 Ambiguity can be overcome by using propositional and semantic analysis techniques (which systematically identify ambiguous areas in the text that lead to misunderstandings) 30 and subsequent disambiguation (establishment of a single semantic interpretation for a recommended statement). 28 Ultimately, each recommendation should specify what action is required, by whom and when (under what specific conditions). 16, 31 Similarly, recommendations for "periodic preand postprandial measurements" (first bullet point in Figure 1 ) and "infrequent [self-monitoring of blood glucose]" (second bullet point) represent a failure to use specific language. Use of "periodic" and "infrequent" leaves the recommendation open to broad interpretation. In turn, this can lead to reduced adherence or increased practice variation, or both. 32 When guideline developers intend to establish "ceilings and floors" around specific actions, use of concrete statements to clarify frequencies and quantities increases the extent to which information is understood and remembered. 16 Figure 2 has several examples of implementability problems related to how guideline content was created. The sample recommendations are from the Canadian Thoracic Society 2012 guideline on the diagnosis and management of asthma. 33 The recommendation for clinicians to change their patient's inhaler device challenges compatibility with existing prescribing habits. Because many clinicians may have a preferred product in each class of inhalers that they are most familiar with, implementation could be limited by both resistance to this change 34 and the cognitive load associated with adopting this change. 35 Also, this represents a new norm, and changes in practice that are incom-patible with existing norms are less likely to be adopted. 13, [36] [37] [38] In situations where such recommendations are unavoidable, implementability can be improved by clearly laying out exactly what changes are required 39 and how the innovation will improve the provider's performance. 40 The recommendation also raises concerns about patient preferences. Patients may be reluctant to change their inhaler device because of personal preference and concerns about adverse effects. 41, 42 The guideline developers themselves acknowledged that a switch to budesonideformoterol has been associated with a twofold increase in discontinuation due to adverse effects. 33, 43 Pressure on physicians to accommodate patient preference plays an important role in guideline adherence. 44 Accordingly, avoiding blanket recommendations in favour of a menu of options allowing clinicians to consider potentially divergent patient choices and values would be expected to improve adherence. 31, 45, 46 This not only reflects users' clinical reality, but it also pre sents an opportunity for shared decisionmaking. 47 Understanding of the breadth of patient preferences can be improved further through direct patient input during guideline development. 48, 49 Guideline developers can also include metrics such as the number needed to treat or harm, which clinicians can use to empower patients to apply their personal values in the shared decision-making process. 50 We also noted that a different section of the same guideline represented in Figure 2 offered a contradictory recommendation (initiation of a leukotriene receptor antagonist) for the same clinical scenario (patients whose asthma is not controlled with the combination of an inhaled corticosteroid and long-acting β-agonist). This contradiction represents a case of pragmatic ambiguity, leaving readers confused as to which of the two recommendations should be applied. 51 The guideline developers could instead have presented both possible courses of action with use of the boolean operator "or" 20 and a list of conditions indicating Proposed revision* For patients with type 2 diabetes not taking insulin, SMBG should be individualized depending on the type of antihyperglycemic agent, as follows:
Example 2
• If the patient is not receiving medications associated with hypoglycemia (as de ned in Table 1 , pages S62-3), we recommend once-or twice-weekly SMBG [Grade D, Consensus] • If the patient is receiving medications associated with hypoglycemia, SMBG frequency should depend on whether the patient is achieving his or her glycemic control target (as de ned in Figure 1 , page S33), as follows:
• If the glycemic control target is being achieved, we recommend once-or twice-weekly SMBG [Grade D, Consensus]
• If the glycemic control target is not being achieved, we recommend [Grade B, Level 2]:
• Pre-and postprandial SMBG with each meal and at bedtime for three consecutive days before an appointment with a provider who is managing the patient's diabetes • Training the patient on methods to modify lifestyle and medications in response to SMBG values, to be performed by any health care provider who is involved in the patient's diabetes care and trained in glycemic control strategies (e.g., primary care provider, specialist physician, nurse, dietitian and/or pharmacist)
How is "not being achieved" de ned? Construct: Language -unambiguous (semantic ambiguity)
What does "periodic" mean? Construct: Language -speci c
What does "infrequent" mean? Construct: Languagespeci c
This bullet de nes a population that is "receiving medications not associated with hypoglycemia," to which the rest of the recommendation does not apply. It is confusing to add this condition at the end. Construct: Language -effective writing How should training be operationalized, and which health care providers should receive it? Constructs: Language -unambiguous (task ambiguity and responsibility ambiguity) when one option should be favoured over the other. The contradictory recommendation was also presented without any level of evidence, thereby failing to meet criteria for completeness of reporting the evidence base. The omission leaves readers unsure about both the quality of underlying evidence and the strength of the corresponding recommendation and lessens the likelihood they will follow the recommendation.
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Example 3 Appendix 3 (available at www.cmaj.ca/lookup/ suppl/doi:10.1503/cmaj.151102/-/DC1) contains several examples of both language and format concerns. The sample recommendations are from the 2014 Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease. 53 In terms of language, one recommendation suggests the addition of a nitrate
Sample recommendation
We suggest the use of a single inhaler of budesonide/formoterol as a reliever and a controller at the same ICS dose be considered in individuals 12 years of age and over with asthma uncontrolled on xed-dose ICS/LABA combination therapy in lieu of increasing the ICS dose of the combination therapy. (GRADE 2B)
• If asthma remains uncontrolled on the combination of an ICS and LABA in individuals 12 years of age and over:
• consider the addition of an LTRA;
• consider referral to a specialist for assessment.
Proposed revision* In individuals 12 years of age and over whose asthma remains uncontrolled (de ned as a failure to ful ll one or more asthma control criteria de ned in Table 16 , page 161) on a xed-dose ICS/LABA combination therapy, rather than increasing the ICS dose of the combination therapy, we suggest either:
• switching to a single inhaler of budesonide-formoterol as both a reliever and a controller. This should be done whether the patient was originally taking budesonide-formoterol, uticasone-salmeterol or mometasone-formoterol, and will result in a lower total daily inhaled corticosteroid dose (NNT = x). For patients originally taking uticasone-salmeterol or mometasone-formoterol, choose the equivalent budesonide-formoterol ICS dose (see dose conversions in Table 3 , page 134) (GRADE 2B) OR • adding a leukotriene receptor antagonist (Consensus)
The choice between these two options should be in uenced by patient preference, comorbidities (leukotriene receptor antagonists can improve allergic rhinitis), drug accessibility and the likelihood of adherence. Adherence is a particular concern if the patient is being switched from a metered-dose inhaler or discus device to a turbuhaler device.
Also consider referral to a specialist for assessment (Consensus) This recommendation is a complex statement with multiple conditions Construct: Language -uncomplicated y (GRA What does "uncontrolled" mean? Construct: Language -speci c A table that de nes "asthma control criteria" is located elsewhere in the guideline, but it is not referenced here Construct: Format -document layout (visual elements) he sa Does this recommendation apply only to patients who are already taking budesonide-formoterol, or should patients taking other combination therapies be switched to budesonide-formoterol? Construct: Language -unambiguous (semantic ambiguity)
A recommendation that involves changing a patient's delivery device may be dif cult for the clinician to accept … Construct: Deliberations and contextualization -compatibility … and for the patient to accept Construct: Deliberations and contextualization -patient/client preferences The level of evidence is missing. Construct: Evidence synthesis -completeness of reporting the evidence base This recommendation from within the same guideline seems to contradict the one above. Which should the practitioner implement? Construct: Language -unambiguous (pragmatic ambiguity) 144 and 158) . 33 Beige boxes: original recommendations with identified problems and corresponding constructs. Blue box: proposed revision. *The proposed revision is for explanatory purposes only and should not be interpreted as an actual guideline recommendation. ICS = inhaled corticosteroid, LABA = long-acting β 2 -agonist, LTRA = leukotriene receptor agonist.
when treatment with a β-blocker and/or a longacting calcium-channel blocker "is not tolerated or contraindicated." Failure to provide a definition or example of intolerance or contraindication constitutes exception ambiguity, whereby the circumstances in which clinicians should make an "exception" to this recommendation (because the risk of the medication outweighs its benefits) are not clearly defined. 54 In another example, a negative recommendation (describing what treatments not to use for angina management) is interspersed with positive recommendations. The word "not" in front of a recommendation is considered a "killer" term, because it is both easy and dangerous to overlook. 55 At best, this creates confusion, slows down the reader 56 and reduces guideline acceptance 57, 58 and compliance. 59 At worst, it leads to an erroneous interpretation of the recommendations. Accordingly, effective writing requires negative recommendations to be clearly separated from positive ones. 55 In another recommendation regarding implementation and optimization of medical therapy, the timelines, patient population and assessment criteria to determine adequacy of therapy are all described in a single sentence (Appendix 3). This recommendation includes multiple steps 37, 57 in a complex decision tree 13, 36, 60 as well as different conditional factors that should influence the clinician's approach. 13, 61 This type of complexity hinders understanding and persuasiveness and may render recommendations more difficult to accept 22, 62 and thus less likely to be implemented. 37, 63 Managing this complexity to produce uncomplicated recommendations requires "atomization" -the process of extracting and presenting individual concepts from the complex recommendation. 64 The same recommendation refers to "high-risk features." Although not referenced specifically, a table located elsewhere in the guideline clearly defines such features. This is a format issue, whereby visual elements (e.g., a table) that is required to understand a recommendation should be easily and quickly accessible to readers. 65, 66 This promotes simplicity and ease of use, 12, 24, 67 both of which influence real-world guideline uptake. 68, 69 Finally, the individual recommendations presented in Appendix 3 are a complex set of interrelated conditional statements and options that must be considered together in order to manage an individual patient's angina. This amount and complexity of information can easily result in "information overload," whereby users become so saturated that important information is lost and the person's interest in the information is diminished. 70 Best information display practices attempt to shift cognitive load to the human perceptual system by presenting information in a visual form that facilitates exploration and understanding and leads to better, faster and more confident decisions. 71 In this case, a flowchart of the clinical decision pathway, such as the one we have created (Appendix 4, available at www.cmaj.ca/lookup/suppl/doi: 10.1503/cmaj.151102 /-/DC1), would enable an understanding of how individual recommendations relate to one another. 72 It could be structured in a sequence that mimics a real patient encounter, enabling users to follow a more natural mapping process and to assimilate information better. 73 When the decision logic is complex and the temporal sequence of activities is unclear, 31 use of such strategies can improve guideline utilization.
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Where do guideline developers go from here?
Improving the intrinsic characteristics of guidelines will require effort by professional societies that produce guidelines, guideline writers themselves and guideline scientists. The first steps are to create awareness among guideline societies and to convince guideline writers of the importance of these issues. Practically, these stakeholders will need to allocate additional time and resources for application of language and format principles in the guideline process. Ideally, end-users of a guideline should also be involved in this process. Recent work suggests that primary care physicians can be successfully engaged in objectively assessing language and format attributes of recommendations and improving these according to their preferences 11 (a worksheet from this process is included in Appendix 5, available at www.cmaj.ca/lookup/ suppl/doi: 10.1503/cmaj.151102/-/DC1). Efforts could be initiated by individual guideline committees. Alternatively, medical societies that produce multiple guidelines may choose to build a team consisting of intended users (e.g., primary care providers), graphic designers and professional writers tasked with assessing and optimizing draft recommendations for multiple guidelines. 13 As a final validation step, optimized recommendations could be pilot tested by real-world users given clinical vignettes to gauge their understanding of the recommendations, 75 with a mechanism for structured feedback for further improvements.
Conclusion
Poor uptake of guidelines continues to be a major challenge across health systems, greatly limiting our ability to deliver the benefits of advancing research to patients. We believe that approaches that focus on factors external to the guideline as well as those that consider intrinsic guideline characteristics will be needed to tackle this challenge.
However, given that conventional external implementation strategies of varying cost and complexity have had only modest impacts on care, addressing how guidelines are written may be the simpler and more cost-effective intervention to augment their uptake. Furthermore, a basic set of such principles is likely to be applicable across content areas and thus easier to implement widely than conventional implementation approaches, which are context dependent. Guideline scientists and guideline developers need to collaborate to establish and refine methods to operationalize these concepts easily, and to measure the impact objectively on both guideline uptake and patientrelevant outcomes.
